Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

What Is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)?

What Is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)?

Your optic nerve carries visual signals from your eye to your brain, and it needs a steady supply of oxygen-rich blood to work properly. When small blood vessels that feed the front part of your optic nerve have reduced perfusion, the nerve tissue can become damaged. This lack of blood supply is often noticed on awakening and may relate to nocturnal factors.

The damage occurs in the optic disc, which is the spot where the optic nerve enters the back of your eye. Without enough oxygen, nerve fibers die and cannot regenerate. Some patients experience partial spontaneous improvement, but deficits commonly persist.

The term 'non-arteritic' means that NAION is not caused by arteritis, which is inflammation of the arteries. This is an important distinction because arteritic ischemic optic neuropathy, caused by a condition called giant cell arteritis, is a medical emergency that requires immediate treatment with steroids to prevent total blindness. Systemic steroids are not proven to improve visual outcomes in NAION and are not routinely recommended.

If giant cell arteritis is suspected, high-dose steroids should be started immediately, even before confirmatory biopsy, to protect vision. We take careful steps to rule out the arteritic form during your evaluation, since the two conditions need very different approaches.

NAION affects about 2 to 10 people per 100,000 each year. Estimates vary by study and population. It is the most common acute optic nerve problem in people over age 50. Men and women are affected at roughly equal rates. Most cases occur in people between ages 50 and 70, though it can happen at younger ages in people with certain risk factors.

Once NAION occurs in one eye, there is about a 15 to 20 percent chance it will eventually affect the other eye over the next several years.

Recognizing the Symptoms and Warning Signs

Recognizing the Symptoms and Warning Signs

The hallmark symptom of NAION is abrupt vision loss in one eye that develops over hours, typically noticed upon waking. Unlike some eye emergencies, NAION is usually painless. You may notice that part of your vision is blurred, dimmed, or completely missing when you open your eyes in the morning.

The vision loss can range from mild blurring to severe reduction, depending on how much of the optic nerve is affected. Some people describe it as a curtain or shadow blocking part of their sight.

NAION often creates specific patterns of vision loss rather than uniform dimming across your entire field of view. Many people develop blind spots, especially in the lower half of their vision. You might find that you can see straight ahead but miss objects below your line of sight, or that one side of your vision is affected more than the other.

  • Difficulty seeing the lower half of your visual field
  • Missing patches that don't go away when you blink or rub your eye
  • Trouble reading because words or letters disappear
  • Problems with depth perception and judging distances

Damage to your optic nerve can affect how you perceive colors and contrast. Colors may appear washed out or less vivid in the affected eye compared to your healthy eye. You might notice that reds look duller or that it is harder to distinguish between similar shades.

Some people also report that their vision seems foggy or that it is harder to see in dim lighting, even in areas where their field of view is not completely blocked.

If you experience sudden vision loss in one eye, you should seek an eye examination as soon as possible. There is no proven vision-restoring emergency treatment for NAION, but same-day evaluation is essential to rule out conditions that do require immediate treatment. Early diagnosis also helps us start managing your underlying health conditions to protect your other eye.

Seek urgent or emergency evaluation if you have:

  • New headache, scalp tenderness, jaw pain with chewing, fever, or weight loss suggesting giant cell arteritis
  • Neurologic symptoms such as speech difficulty, weakness, or facial droop
  • Sudden profound vision loss, curtain-like shadow, or new flashes and floaters suggesting retinal emergency
  • Inability to reach an eye doctor the same day, in which case go to an emergency department

Delaying evaluation can mean missing the window to treat other potentially reversible causes of vision loss.

Risk Factors and Causes

Several chronic health conditions make NAION more likely by affecting your blood vessels and circulation. High blood pressure is present in many NAION patients, and diabetes also increases your risk because it damages small blood vessels throughout your body, including those that supply your optic nerve. High cholesterol, heart disease, and a history of blood clots can all contribute as well.

  • High blood pressure, especially if poorly controlled
  • Diabetes and related blood vessel damage
  • High cholesterol and atherosclerosis
  • History of heart attack or stroke
  • Smoking, which damages blood vessels

In younger patients or atypical presentations, additional evaluation may include testing for blood clotting disorders, severe anemia, or other less common contributors.

Some people are born with a structural feature that puts them at higher risk for NAION. If your optic disc has a small cup or no cup at all, it is called a 'crowded disc.' This means the nerve fibers are packed tightly together as they exit the eye, leaving little room for swelling. When blood flow drops even slightly, nerve fibers in a crowded disc are more likely to become compressed and damaged.

We can see this anatomical feature during your eye exam by looking at the back of your eye. People with crowded discs in both eyes have a higher risk of NAION in either eye.

Obstructive sleep apnea is increasingly recognized as a risk factor for NAION. When you stop breathing repeatedly during sleep, oxygen levels drop and blood flow patterns change. In addition, blood pressure naturally dips at night in many people, and an excessive nighttime drop can reduce blood flow to the optic nerve enough to cause damage, especially if you also have sleep apnea or a crowded disc.

If you have been diagnosed with NAION and have symptoms of sleep apnea such as snoring or daytime sleepiness, a sleep study may be recommended.

Certain medications have been associated with NAION, though the link is still being studied. Some drugs used to treat erectile dysfunction have been reported in connection with NAION cases, and medications that lower blood pressure significantly, especially at night, may increase risk. Other medications have been reported in association with optic neuropathy (for example, amiodarone), so medication review is individualized. Anemia, major surgeries with blood loss, and acute illnesses that drop blood pressure can also trigger NAION in susceptible individuals.

Do not stop or change prescription medications without coordinating with the prescribing clinician. Your eye doctor may review all your medications and recent health events as part of your evaluation to identify any potential contributing factors.

How We Diagnose NAION

When you come in with sudden vision loss, we begin with a thorough eye exam that includes checking your visual acuity and pupil reactions. We will carefully examine the back of your eye with special lenses to look at your optic disc. In NAION, the optic disc typically appears swollen, often segmental and hyperemic, with possible peripapillary hemorrhages. A markedly pallid swollen disc raises concern for arteritic ischemic optic neuropathy. We also compare the appearance of both eyes to check for crowded discs.

Testing typically includes checking for a relative afferent pupillary defect (unless both eyes are affected) and assessing color vision and contrast sensitivity. We may test your eye movements, check for pain with eye movement, and examine other structures to rule out different causes of vision loss.

Optical coherence tomography, or OCT, is a non-invasive imaging test that takes detailed cross-sectional pictures of your retina and optic nerve. This test helps us measure the amount of swelling in your optic disc and can detect subtle changes over time. Fluorescein angiography may be used in selected cases to assess blood flow patterns in your retina and optic nerve.

  • OCT to measure optic nerve swelling and thickness
  • Fundus photography to document the appearance of your optic disc
  • Fluorescein angiography in selected cases to assess blood flow patterns

If the presentation is atypical (painful, progressive beyond about two weeks, bilateral, younger age, or unusual exam findings), orbital or brain MRI may be used to evaluate alternative causes.

One of our most important tasks is to make sure your vision loss is not caused by giant cell arteritis, which requires urgent steroid treatment. Blood tests typically include erythrocyte sedimentation rate, or ESR, C-reactive protein, or CRP, and platelet count. Elevated levels suggest inflammation and arteritis. Normal inflammatory markers do not fully exclude giant cell arteritis when clinical suspicion is high. If these tests are elevated or you have symptoms such as headache, jaw pain, or scalp tenderness, a temporal artery biopsy may be recommended. When giant cell arteritis is suspected, treatment should not be delayed while awaiting biopsy.

Even if you feel well otherwise, these tests are performed because giant cell arteritis can occur without obvious symptoms, and missing it could lead to blindness in both eyes.

A visual field test measures your complete range of vision and creates a detailed map showing exactly where you have blind spots or reduced sensitivity. You will look into a machine and press a button whenever you see a flash of light. This test helps us understand the pattern and extent of your vision loss, which is helpful for diagnosis and for tracking whether your vision changes over time.

NAION often causes altitudinal defects (commonly inferior) or arcuate patterns, though other patterns can occur.

Treatment Options and What to Expect

Treatment Options and What to Expect

Unfortunately, as of 2025, there is no treatment proven to restore vision lost to NAION. Many therapies have been studied, including steroids, blood thinners, and procedures to relieve pressure on the optic nerve, but none have shown consistent benefit in scientific trials. The optic nerve damage happens quickly, and once nerve fibers die, they cannot regenerate or be repaired with current medical technology. Vision may worsen for several days before stabilizing, then partial improvement can occur over months in some patients.

While this is difficult news, understanding this helps set realistic expectations and allows us to focus on protecting your other eye and managing conditions that contributed to NAION.

The most important step after a NAION diagnosis is to work with your doctors to control the health problems that increase your risk. Your eye doctor may coordinate with your primary care doctor to optimize your blood pressure, blood sugar, and cholesterol levels. If you smoke, quitting is one of the most helpful things you can do. If you have sleep apnea, treatment with a CPAP machine or other therapy is recommended for overall health and may help reduce your risk of NAION in your other eye.

  • Control high blood pressure to a healthy target range
  • Manage diabetes with medication and lifestyle changes
  • Lower cholesterol with diet, exercise, or medication
  • Treat obstructive sleep apnea if diagnosed
  • Stop smoking to protect your blood vessels

Some eye doctors recommend low-dose aspirin after NAION to help prevent blood clots and improve blood flow, though evidence supporting this is limited. Aspirin may be particularly reasonable if you already have indications for it, such as heart disease. Your doctor may discuss whether aspirin is appropriate for you based on your overall health and bleeding risk. Aspirin has not been proven to prevent NAION in the other eye. Use is generally guided by cardiovascular indications and bleeding risk.

Other blood flow therapies such as medications to lower eye pressure or improve circulation are sometimes considered, but these remain unproven for NAION in 2025.

Researchers continue to study new approaches for NAION, including nerve-protecting drugs, anti-inflammatory medications, and stem cell therapies. Some of these are being tested in clinical trials. If you are interested in participating in research, your doctor can discuss whether any trials are available and appropriate for your situation.

Experimental treatments may be recommended only in the context of well-designed studies, with clear discussion of uncertain benefits and potential risks.

Living with NAION and Protecting Your Remaining Vision

If NAION has left you with significant vision loss, vision rehabilitation can help you make the most of your remaining sight. Low vision specialists can teach you techniques to work around blind spots and recommend devices such as magnifiers, special lighting, or electronic aids. Many people find these services greatly improve their ability to read, perform hobbies, and stay independent.

  • Magnifying glasses for reading and close-up tasks
  • Large-print books, phones, and computer settings
  • Improved lighting at home and work
  • Training to use your remaining vision more effectively

Because NAION can occur in your second eye, protecting it becomes a top priority. This means rigorously managing all the risk factors we have discussed, including blood pressure, diabetes, cholesterol, and sleep apnea. Some evidence suggests that the risk is highest in the first few years after your first episode, so vigilance during this period is especially important.

Discuss timing and intensity of blood pressure treatment with your clinician to avoid excessive nocturnal hypotension. There is no proven medication or procedure that prevents fellow-eye involvement, so lifestyle and medical management of vascular risk factors remain our best tools.

After your NAION diagnosis, you will typically be seen regularly to monitor your affected eye and watch for any changes in your other eye. Early follow-up is often within weeks to monitor disc edema evolution and to document visual field status. Initial visits may be more frequent to track the evolution of optic disc swelling, which typically peaks within a few weeks and then gradually resolves. Long-term follow-up usually involves eye exams every 6 to 12 months to check your optic nerves, visual fields, and overall eye health.

These visits allow early detection of new problems and adjustment of your care plan as needed.

Vision loss from NAION can affect your ability to drive safely, especially if it involves your lower visual field or reduces your side vision. Depending on the extent of your vision loss, you may need to limit or stop driving. We can perform or refer you for a driving assessment if there is any question. Driving eligibility depends on jurisdictional visual acuity and visual field requirements. Formal testing may be needed.

For daily activities, you may need to make adjustments such as using handrails on stairs, organizing your home to avoid tripping hazards, and asking for help with tasks that require full vision. Being honest about your limitations and making smart adaptations can keep you safe and active.

Frequently Asked Questions

Most people with NAION do not experience significant vision recovery, though about 40 percent may notice some improvement in the first few months as optic disc swelling goes down. Any recovery that happens is usually partial and occurs within the first six months, with little change after that. Unfortunately, vision loss from NAION is typically permanent because the optic nerve fibers have been permanently damaged.

Yes, there is about a 15 to 20 percent chance that NAION will eventually occur in your second eye, often within the first five years. This risk underscores the importance of managing your underlying health conditions and attending regular eye exams so we can monitor your unaffected eye closely.

NAION and stroke both involve problems with blood flow, and they share many of the same risk factors such as high blood pressure, diabetes, and high cholesterol. However, NAION specifically affects the small vessels supplying the optic nerve, while stroke involves blood vessels in the brain. Having NAION does not directly cause stroke, but the shared risk factors mean that managing your vascular health protects you against both conditions.

NAION rarely causes complete blindness, even in the affected eye. Most people retain some useful vision, although it may be significantly reduced or limited to certain areas. Total blindness in both eyes from NAION is uncommon because the condition usually affects only one eye, and even when it occurs in both eyes, some vision typically remains in at least one.

Some reports have linked erectile dysfunction drugs to NAION, though the exact relationship is still debated and studied. If you have had NAION and are taking these medications, we recommend discussing the risks and benefits with both your eye doctor and the physician who prescribed the medication. Some experts suggest avoiding these drugs after NAION, especially in the unaffected eye, but the decision depends on your individual situation.

Surgery has been attempted for NAION, including a procedure called optic nerve sheath decompression, but studies have not shown that it improves outcomes and it may even cause harm. As of 2025, surgery is not recommended for NAION. Our focus remains on medical management of risk factors and rehabilitation for vision loss rather than surgical intervention.

Getting Help for Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Getting Help for Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

If you experience sudden vision loss in one eye, contact an eye doctor immediately for a comprehensive evaluation. Early diagnosis helps rule out treatable causes and begin protecting your remaining vision through careful management of your health conditions.